Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released May 10, 2018, after the close
10-Q filed May 10, 2018, 40 days after period end · 0000320017-18-000038
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Revenue | — | $7.92M | $7.49M | $3.17M |
| Net Income | -$4.98M | -$9.79M | -$12.05M | -$19.19K |
| EPS Diluted |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$0.52 |
| -$1.12 |
| -$2.09 |
| -$0.51 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
